ALLMedicine™ Menkes Disease Center
Research & Reviews 101 results
https://doi.org/10.1136/bcr-2021-247937
BMJ Case Reports; Panichsillaphakit E, Kwanbunbumpen T et. al.
Apr 9th, 2022 - Menkes disease (MD) is an X linked recessive multi-systemic disorder of copper metabolism, resulting from an ATP7A gene mutation. We report a male infant aged 4 months who presented with kinky hair, hypopigmented skin, epilepsy and delayed develop...
https://doi.org/10.1016/j.xphs.2022.03.015
Journal of Pharmaceutical Sciences; Dwiecki PM, Wróblewska KB et. al.
Mar 29th, 2022 - Copper (II) histidinate injection solution, applied in Menkes disease treatment, is characterized by low stability due to sensitivity to oxidation. The aim of this article was to determine the critical points of the injection preparation procedure...
https://doi.org/10.1055/a-1762-0354
Neuropediatrics Means MJ, Santos FJR et. al.
Feb 6th, 2022 - Menkes Disease: Clinical Presentation and Imaging Characteristics.|2022|Means MJ,Santos FJR,Sotardi ST,Beslow LA,|
https://doi.org/10.1007/s11095-021-03090-0 10.1038/ejhg.2009.187 10.1038/ng0193-7 10.1038/ng0193-14 10.1038/ng0193-20 10.1038/ng1094-195 10.1136/jmg.34.4.265 10.1152/physrev.00004.2006 10.1016/j.brainres.2008.10.056 10.1016/S0022-3476(05)80870-4 10.1016/j.braindev.2010.10.021 10.1371/journal.pone.0040400 10.1007/s10545-005-0150-6 10.1016/j.jtemb.2012.05.002 10.1016/j.jtemb.2012.04.017 10.1039/c0cs00215a 10.1016/j.tranon.2019.05.017 10.1073/pnas.0809057106 10.1128/AAC.01781-12 10.2967/jnumed.107.048520 10.1007/s10350-008-9420-3 10.2967/jnumed.108.051326 10.1038/pr.2012.85 10.1038/s41390-018-0116-7 10.1021/acs.inorgchem.0c00182 10.1016/j.addr.2006.09.009 10.2147/IJN.S213831 10.1139/v62-161 10.1002/anie.200801936 10.1074/jbc.M116.727248
Pharmaceutical Research; Yamagishi Y, Kudo T et. al.
Aug 18th, 2021 - Menkes disease is a rare hereditary disease in which systemic deficiency of copper due to mutation of the ATP7A gene causes severe neurodegenerative disorders. The present parenteral drugs have limited efficacy, so there is a need for an efficacio...
https://clinicaltrials.gov/ct2/show/NCT04337684
Jul 28th, 2021 - Primary Objective: To provide additional clinical and safety data on long term following administration of Copper Histidinate treatment in patients treated with Copper Histidinate under Protocols 09-CH-0059 and 90-CH0149 and untreated patients pre...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT04337684
Jul 28th, 2021 - Primary Objective: To provide additional clinical and safety data on long term following administration of Copper Histidinate treatment in patients treated with Copper Histidinate under Protocols 09-CH-0059 and 90-CH0149 and untreated patients pre...
News 1 results
https://www.medpagetoday.com/pediatrics/generalpediatrics/35114
Oct 3rd, 2012 - Action Points Rapid whole-genome testing of critically ill newborns may improve diagnosis and, in some cases, treatment, researchers have found. Note that the new approach combines more rapid genetic sequencing with software that can help focus in...
